Recent
Updates
2023-10-08
NuraLogix Announces Integration Availability of its Highly Anticipated
Anura™ Telehealth Platform
NuraLogix, a global pioneer in Affective Ai1, is pleased to announce the availability of its highly-anticipated Anura™ Telehealth
solution for integration into healthcare professionals’ telehealth offerings. Powered by our cloud based Affective Ai platform,
DeepAffex™, Anura™ Telehealth enables real-time assessment of vital signs during video consultation sessions.
2023-08-11
NuraLogix featured on CNN’s The Next Frontier : Could Selfies Provide Health Insights?
Anura™ was featured on CNN ‘The Next Frontier’ series as a pioneering technology set to revolutionize the healthcare industry.
2023-04-17
NuraLogix Researchers Announce the Capability to Predict Risk for Fatty Liver Disease and Blood Biomarker Health Issues Using Any Video-Enabled Device
Researchers at NuraLogix, a global pioneer of contactless health monitoring through its patented Transdermal Optical Imaging (TOI™) technology, have announced they have developed AI models that can predict a person’s risk of having fatty liver disease (FLD) using facial blood flow patterns.
2023-01-25
Agreement between Telepass
and Neocogita for road safety
2023-01-05
NuraLogix won CES®
2023 Innovation Awards
honoree, in the ‘Digital Health’
category
2023-01-05
CES 2023: NuraLogix Unveils Anura™ Telehealth Allowing Continuous Health and Vital Sign Measurements To be Taken on Video Calls
NuraLogix, global pioneers of contactless health monitoring whose technology can take over 30 medical-grade health vitals using any video-enabled device, unveils Anura™ Telehealth, a platform that performs continuous health and vital sign measurements while on a video call.
2023-01-05
CES 2023: The ‘Healthy Selfie’ Arrives As NuraLogix Unveils The Ability To Perform Continuous Health and Vital Sign Measurements on Video Calls
2023-01-04
NuraLogix Announces Holy
Grail of Blood Pressure
Measurement
Researchers at NuraLogix, a global leader in Health Tech AI,
announced today that they have achieved the ‘Holy Grail’ of
contactless blood pressure (BP) measurement using the
company’s TOI™ based Anura™ app.
2022-11-14
HLTH 2022: NuraLogix
researchers announce the
capability to assess Type 2
diabetes and blood biomarker
health issues using any video-
enabled device
Researchers at NuraLogix, a global pioneer of contactless health monitoring through its patented Transdermal Optical Imaging (TOI™) technology, has announced that it is adding the ability to perform metabolic and blood biomarker health risk assessments for various chronic conditions to its Anura platform.
2022-08-11
NuraLogix partners with 5-HT Digital Innovation Hub
2022-08-08
FWD Group introduces omne, a new app for changing the way people feel about insurance
2022-06-29
NuraLogix at AHIP, Las Vegas,
Nevada
2022-02-17
NTT Data Selects NuraLogix
NTT DATA, a global digital business and IT services leader, today announced that it began providing a “Vitals Measurement Service” on a commercial basis from January 2022 as a new function of its cloud-based health management solution Health Data Bank®.
2020-10-08
Sanitas launches BluaU app
Sanitas launches BluaU app with Anura™ technology, a major step forward in digital health.
Xinhuanet 2019-08-06
U of T News 2017-03-24
Quick Links
Corporate Headquarters
NuraLogix Corporation
Toronto, Canada
250 University Avenue, Suite 209
Toronto, ON, Canada M5H 3E5
Email: info@nuralogix.ai
Phone: +1 (416) 368-6000
In the United States, this product is for Investigational Use Only. The performance characteristics of this product have not been established.
© Copyright NuraLogix Corporation
Regional Offices
North America
sales-na@nuralogix.ai
Latin America and EMEA (Europe, Middle East and Africa)
sales-emea@nuralogix.ai
APAC (Asia-Pacific)
sales-apac@nuralogix.ai
China (Mainland)
sales-china@nuralogix.ai